| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Extracorporeal Circulation | 4 | 2020 | 130 | 1.62 | Why? |
| Extracorporeal Membrane Oxygenation | 17 | 2020 | 5002 | 1.38 | Why? |
| Positive-Pressure Respiration | 10 | 2020 | 1160 | 1.27 | Why? |
| Carbon Dioxide | 4 | 2020 | 917 | 1.12 | Why? |
| Work of Breathing | 3 | 2018 | 86 | 0.80 | Why? |
| Inhalation | 1 | 2018 | 86 | 0.72 | Why? |
| Ventilator-Induced Lung Injury | 3 | 2017 | 260 | 0.70 | Why? |
| Hyperventilation | 1 | 2017 | 59 | 0.68 | Why? |
| Poetry as Topic | 1 | 2017 | 27 | 0.66 | Why? |
| Deep Sedation | 1 | 2018 | 121 | 0.66 | Why? |
| Respiratory Insufficiency | 13 | 2021 | 7301 | 0.66 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.65 | Why? |
| Propofol | 1 | 2018 | 172 | 0.61 | Why? |
| Diaphragm | 1 | 2018 | 232 | 0.59 | Why? |
| Respiration, Artificial | 27 | 2021 | 22116 | 0.57 | Why? |
| Psoas Muscles | 1 | 2014 | 28 | 0.55 | Why? |
| Death | 1 | 2017 | 334 | 0.52 | Why? |
| Hernia, Inguinal | 1 | 2014 | 51 | 0.52 | Why? |
| Fluid Therapy | 2 | 2017 | 628 | 0.52 | Why? |
| Blood Gas Analysis | 5 | 2020 | 893 | 0.51 | Why? |
| Lymphoma | 1 | 2018 | 522 | 0.50 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 526 | 0.49 | Why? |
| Transportation of Patients | 1 | 2018 | 494 | 0.48 | Why? |
| Respiratory Mechanics | 4 | 2021 | 585 | 0.47 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2018 | 676 | 0.44 | Why? |
| Intensive Care Units | 23 | 2021 | 29594 | 0.44 | Why? |
| Tidal Volume | 6 | 2020 | 565 | 0.43 | Why? |
| Nerve Block | 1 | 2014 | 183 | 0.42 | Why? |
| Critical Illness | 11 | 2021 | 17281 | 0.42 | Why? |
| Noninvasive Ventilation | 5 | 2021 | 2329 | 0.39 | Why? |
| Hypoxia | 8 | 2021 | 3626 | 0.38 | Why? |
| Intubation | 3 | 2021 | 437 | 0.38 | Why? |
| Civil Defense | 1 | 2021 | 1687 | 0.37 | Why? |
| Prone Position | 5 | 2021 | 1861 | 0.36 | Why? |
| Shock, Septic | 4 | 2018 | 1313 | 0.35 | Why? |
| Critical Care | 12 | 2021 | 14081 | 0.34 | Why? |
| Pressure | 2 | 2020 | 289 | 0.34 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.33 | Why? |
| Cannula | 4 | 2021 | 750 | 0.31 | Why? |
| Iatrogenic Disease | 2 | 2018 | 304 | 0.30 | Why? |
| Sepsis | 6 | 2021 | 3517 | 0.28 | Why? |
| Cross-Over Studies | 4 | 2020 | 867 | 0.27 | Why? |
| Anesthesia, General | 2 | 2018 | 470 | 0.26 | Why? |
| Pneumonia, Ventilator-Associated | 4 | 2021 | 861 | 0.25 | Why? |
| Anesthesia | 1 | 2014 | 1236 | 0.25 | Why? |
| Italy | 22 | 2021 | 38444 | 0.25 | Why? |
| Lung Compliance | 2 | 2021 | 243 | 0.25 | Why? |
| Cross Infection | 3 | 2021 | 8675 | 0.23 | Why? |
| Albumins | 3 | 2018 | 324 | 0.22 | Why? |
| Adrenal Hyperplasia, Congenital | 1 | 2021 | 24 | 0.22 | Why? |
| Resuscitation | 3 | 2017 | 638 | 0.22 | Why? |
| Humans | 88 | 2021 | 930598 | 0.22 | Why? |
| Male | 53 | 2021 | 367725 | 0.21 | Why? |
| Supine Position | 1 | 2021 | 158 | 0.21 | Why? |
| Hospital Mortality | 10 | 2021 | 22087 | 0.21 | Why? |
| Middle Aged | 45 | 2021 | 270681 | 0.20 | Why? |
| Intercostal Muscles | 1 | 2018 | 5 | 0.20 | Why? |
| Barotrauma | 1 | 2020 | 97 | 0.20 | Why? |
| Dental Care for Chronically Ill | 1 | 2018 | 6 | 0.20 | Why? |
| Receptors, Interleukin-1 | 1 | 2020 | 161 | 0.19 | Why? |
| Enkephalins | 1 | 2018 | 10 | 0.19 | Why? |
| Intraoperative Complications | 2 | 2018 | 221 | 0.19 | Why? |
| Ultrasonography, Doppler, Duplex | 1 | 2020 | 168 | 0.19 | Why? |
| Secretogranin II | 1 | 2018 | 3 | 0.19 | Why? |
| Pleura | 1 | 2020 | 178 | 0.19 | Why? |
| Organ Dysfunction Scores | 3 | 2020 | 1475 | 0.19 | Why? |
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 56 | 0.19 | Why? |
| Mucopolysaccharidoses | 1 | 2018 | 18 | 0.18 | Why? |
| Bacterial Load | 1 | 2019 | 179 | 0.18 | Why? |
| Chromosomes, Human, Pair 3 | 1 | 2020 | 195 | 0.18 | Why? |
| Patient Positioning | 2 | 2021 | 1505 | 0.18 | Why? |
| Female | 48 | 2021 | 380317 | 0.18 | Why? |
| Forced Expiratory Flow Rates | 1 | 2017 | 9 | 0.18 | Why? |
| Nursing Assessment | 1 | 2018 | 72 | 0.18 | Why? |
| Hypotension | 2 | 2018 | 392 | 0.18 | Why? |
| Hypoxia, Brain | 1 | 2018 | 92 | 0.18 | Why? |
| Head-Down Tilt | 1 | 2017 | 13 | 0.18 | Why? |
| Nursing Process | 1 | 2018 | 62 | 0.18 | Why? |
| Persia | 1 | 2017 | 9 | 0.18 | Why? |
| Intubation, Intratracheal | 5 | 2021 | 3962 | 0.18 | Why? |
| Airway Obstruction | 1 | 2020 | 182 | 0.17 | Why? |
| Intraoperative Care | 1 | 2019 | 238 | 0.17 | Why? |
| Citric Acid | 1 | 2018 | 116 | 0.17 | Why? |
| Patient Comfort | 1 | 2018 | 74 | 0.17 | Why? |
| Neuropeptides | 1 | 2018 | 91 | 0.17 | Why? |
| Patient Outcome Assessment | 2 | 2019 | 707 | 0.17 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2018 | 100 | 0.17 | Why? |
| Water-Electrolyte Balance | 1 | 2017 | 136 | 0.17 | Why? |
| History, Medieval | 1 | 2017 | 131 | 0.16 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.16 | Why? |
| Microbiology | 1 | 2019 | 134 | 0.16 | Why? |
| Abdomen | 1 | 2020 | 424 | 0.16 | Why? |
| Oxygen Consumption | 2 | 2019 | 711 | 0.16 | Why? |
| Prospective Studies | 16 | 2021 | 43301 | 0.16 | Why? |
| Ventilators, Mechanical | 2 | 2020 | 2193 | 0.16 | Why? |
| Serum Albumin, Human | 1 | 2018 | 265 | 0.16 | Why? |
| Patients' Rooms | 1 | 2021 | 675 | 0.16 | Why? |
| Blood Coagulation | 2 | 2020 | 2768 | 0.15 | Why? |
| Treatment Failure | 2 | 2021 | 2106 | 0.15 | Why? |
| Aged | 31 | 2021 | 215776 | 0.15 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.15 | Why? |
| Hypercapnia | 1 | 2017 | 172 | 0.15 | Why? |
| Continuous Positive Airway Pressure | 2 | 2021 | 1187 | 0.15 | Why? |
| Ambulances | 1 | 2018 | 287 | 0.15 | Why? |
| Lactic Acid | 1 | 2018 | 393 | 0.14 | Why? |
| Thrombelastography | 1 | 2020 | 627 | 0.14 | Why? |
| Adrenomedullin | 1 | 2017 | 217 | 0.14 | Why? |
| Status Epilepticus | 1 | 2018 | 303 | 0.14 | Why? |
| Protein Precursors | 1 | 2018 | 425 | 0.14 | Why? |
| Complement Activation | 1 | 2020 | 949 | 0.13 | Why? |
| Aircraft | 1 | 2018 | 498 | 0.13 | Why? |
| Blood Chemical Analysis | 1 | 2018 | 541 | 0.13 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2021 | 10649 | 0.13 | Why? |
| Expert Testimony | 1 | 2017 | 658 | 0.13 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.13 | Why? |
| Retrospective Studies | 17 | 2021 | 105322 | 0.13 | Why? |
| Developed Countries | 1 | 2017 | 500 | 0.13 | Why? |
| Oxygen Inhalation Therapy | 4 | 2021 | 3629 | 0.12 | Why? |
| Trauma Centers | 1 | 2021 | 1195 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.12 | Why? |
| Oxygen | 3 | 2020 | 3715 | 0.12 | Why? |
| Postoperative Complications | 3 | 2019 | 5861 | 0.11 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.11 | Why? |
| Biomedical Research | 4 | 2020 | 5270 | 0.11 | Why? |
| Pressure Ulcer | 1 | 2017 | 398 | 0.11 | Why? |
| Respiratory Rate | 3 | 2020 | 691 | 0.11 | Why? |
| Cell Phone | 1 | 2019 | 750 | 0.11 | Why? |
| Adult | 26 | 2021 | 244371 | 0.11 | Why? |
| ABO Blood-Group System | 1 | 2020 | 995 | 0.11 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.11 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.11 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.11 | Why? |
| Preoperative Care | 2 | 2019 | 1515 | 0.11 | Why? |
| Pulmonary Gas Exchange | 3 | 2018 | 414 | 0.10 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.10 | Why? |
| Mycoses | 1 | 2017 | 589 | 0.10 | Why? |
| Hemofiltration | 1 | 1991 | 155 | 0.10 | Why? |
| Lung | 5 | 2020 | 31049 | 0.10 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.10 | Why? |
| Cystic Fibrosis | 1 | 2019 | 1104 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.10 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.09 | Why? |
| Wounds and Injuries | 1 | 2021 | 1708 | 0.09 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Incidence | 6 | 2020 | 25622 | 0.09 | Why? |
| Lung Transplantation | 1 | 2019 | 1554 | 0.09 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Income | 1 | 2017 | 1564 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Biomarkers | 6 | 2020 | 23361 | 0.09 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.08 | Why? |
| Heart | 1 | 2017 | 1791 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.08 | Why? |
| Cohort Studies | 8 | 2021 | 36005 | 0.08 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.07 | Why? |
| Brain Diseases | 1 | 2017 | 1463 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| Risk Factors | 12 | 2021 | 71621 | 0.07 | Why? |
| Acute Kidney Injury | 2 | 2018 | 5762 | 0.07 | Why? |
| Statistics, Nonparametric | 2 | 2018 | 1008 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.07 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.07 | Why? |
| Registries | 2 | 2021 | 12327 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Subthalamic Nucleus | 1 | 2003 | 36 | 0.06 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.06 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.06 | Why? |
| Observational Studies as Topic | 2 | 2021 | 1887 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.06 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.06 | Why? |
| History, 20th Century | 2 | 2018 | 1282 | 0.05 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Air Pressure | 1 | 2020 | 119 | 0.05 | Why? |
| Electric Stimulation Therapy | 1 | 2003 | 151 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Injury Severity Score | 1 | 2021 | 287 | 0.05 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.05 | Why? |
| Chromosomes, Human, Pair 9 | 1 | 2020 | 196 | 0.05 | Why? |
| Early Diagnosis | 2 | 2020 | 2443 | 0.05 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.05 | Why? |
| Child | 3 | 2018 | 70012 | 0.05 | Why? |
| Child, Preschool | 3 | 2018 | 36283 | 0.05 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.05 | Why? |
| Multigene Family | 1 | 2020 | 377 | 0.05 | Why? |
| Age of Onset | 1 | 2021 | 557 | 0.05 | Why? |
| Partial Pressure | 1 | 2019 | 279 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2018 | 151 | 0.04 | Why? |
| Obesity | 1 | 2019 | 7388 | 0.04 | Why? |
| Chest Wall Oscillation | 1 | 2017 | 17 | 0.04 | Why? |
| Head Protective Devices | 1 | 2019 | 163 | 0.04 | Why? |
| Sierra Leone | 1 | 2018 | 267 | 0.04 | Why? |
| Muscles | 1 | 2018 | 152 | 0.04 | Why? |
| Shock, Cardiogenic | 1 | 2004 | 700 | 0.04 | Why? |
| Isotonic Solutions | 1 | 2017 | 69 | 0.04 | Why? |
| Treatment Outcome | 6 | 2018 | 51732 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Coma | 1 | 2018 | 204 | 0.04 | Why? |
| Respiratory Physiological Phenomena | 1 | 2018 | 157 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Cardiac Catheterization | 1 | 2004 | 882 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2021 | 632 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2018 | 520 | 0.04 | Why? |
| APACHE | 1 | 2018 | 682 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2019 | 961 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Anesthetics | 1 | 2018 | 196 | 0.04 | Why? |
| Risk Adjustment | 1 | 2019 | 730 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Causality | 1 | 2018 | 857 | 0.03 | Why? |
| Geography, Medical | 1 | 2017 | 537 | 0.03 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.03 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.03 | Why? |
| Catheter-Related Infections | 1 | 2017 | 381 | 0.03 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2018 | 458 | 0.03 | Why? |
| Fibrinolysis | 1 | 2018 | 521 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2019 | 639 | 0.03 | Why? |
| Critical Care Nursing | 1 | 2018 | 469 | 0.03 | Why? |
| Ventilator Weaning | 1 | 2017 | 536 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.03 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.03 | Why? |
| Electroencephalography | 1 | 2018 | 1242 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.03 | Why? |
| Airway Management | 1 | 2021 | 1298 | 0.03 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.03 | Why? |
| Parkinson Disease | 1 | 2003 | 1414 | 0.03 | Why? |
| Cesarean Section | 1 | 2021 | 2089 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.03 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.03 | Why? |
| Patient Care | 1 | 2021 | 1664 | 0.02 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.02 | Why? |
| Home Care Services | 1 | 2021 | 1351 | 0.02 | Why? |
| Stroke Volume | 1 | 2019 | 2153 | 0.02 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2020 | 2654 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.02 | Why? |
| Delirium | 1 | 2018 | 1061 | 0.02 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.02 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Pregnant Women | 1 | 2021 | 2535 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.02 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2017 | 1724 | 0.02 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2003 | 6551 | 0.02 | Why? |
| Internationality | 1 | 2019 | 3297 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Red Nucleus | 1 | 2003 | 2 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2018 | 2040 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Stereotaxic Techniques | 1 | 2003 | 19 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Life Support Care | 1 | 2004 | 161 | 0.02 | Why? |
| Levodopa | 1 | 2003 | 87 | 0.02 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.01 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Antiparkinson Agents | 1 | 2003 | 125 | 0.01 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.01 | Why? |
| Postoperative Period | 1 | 2003 | 651 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Heart Transplantation | 1 | 2004 | 1293 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2003 | 3776 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.01 | Why? |
| Infection Control | 1 | 2017 | 23131 | 0.01 | Why? |